Drug Profile
WC 3016
Alternative Names: WC3016Latest Information Update: 10 Dec 2013
Price :
$50
*
At a glance
- Originator Warner Chilcott
- Developer Actavis Inc
- Class Contraceptives
- Mechanism of Action Hormone modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pregnancy